The proposed bill would amend several sections of the Arizona Revised Statutes related to the Controlled Substances Prescription Monitoring Program (CSPMP). Key updates include the removal of the requirement for the CSPMP database to track the consumption of controlled substances, replacing affidavits with search warrants for law enforcement investigations, and substituting the existing CSPMP Task Force with a Compliance Workgroup to oversee compliance with CSPMP requirements. Additionally, the bill modifies the definition of "delegate" to include pharmacy technician trainees and requires medical practitioners to obtain a 12-month patient utilization report before prescribing certain controlled substances, rather than at the beginning of each new treatment course.

Further changes involve the requirement for pharmacies to adhere to CSPMP reporting requirements, including reporting the date a prescription was filled and sold to the user starting July 1, 2027. The bill also mandates that dispensers submit required information to the CSPMP within one business day after a prescription is sold, including reporting zero transactions if applicable. Other provisions include aligning the privacy requirements to cover all dispensing data, removing the authority for waivers from electronic reporting, and making various technical and conforming changes to ensure the effective administration of the CSPMP.

Statutes affected:
Introduced Version: 36-2525, 36-2602, 36-2603, 36-2604, 36-2606, 36-2608, 32-1968, 36-2523, 32-3201.01, 36-2610, 32-1904, 12-2293, 23-1026, 11-593, 36-198, 36-2901, 11-594, 20-3151
House Engrossed Version: 36-2525, 36-2602, 36-2603, 36-2604, 36-2606, 36-2608, 32-1968, 36-2523, 32-3201.01, 36-2610, 32-1904, 12-2293, 23-1026, 11-593, 36-198, 36-2901, 11-594, 20-3151